报价延迟最少15分钟:2025/07/20 16:52 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
7.54 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-22.65/--
|
|
企业价值
4.31M
|
| 资产负债 |
|
每股账面净值
15.25
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
1.31M
|
|
每股收益
6.21
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/07/20 16:52 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. |
